Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma

Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma

Background/ObjectiveWe aimed to explore the prognostic value of regression rate (RR) of plasma Epstein–Barr virus (EBV) DNA after induction chemotherapy (IC) in patients with stages II–IVA nasopharyngeal carcinoma (NPC).MethodsEligible patients receiving IC followed by concurrent chemoradiotherapy w...

Full description

Bibliographic Details
Main Authors: Hao Peng, Bin-bin Chen, Xiao-hui Wang, Yun-Xian Mo, Fei Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
decrease rate
Epstein-Barr virus
nasopharyngeal carcinoma
induction chemotherapy
cumulative platinum dose
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.689593/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.689593/full

Similar Items